Orange Book product · Generic (ANDA)
AMPHETAMINE SULFATE
AMPHETAMINE SULFATE
At a glance
Jul 14, 2020
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 14, 2020
6 yr ago
Today
Pharmaceutical detail
Active ingredient
AMPHETAMINE SULFATE
Strength
5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 213898
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of AMPHETAMINE SULFATE
- 2021EVEKEO ODTBrand (NDA)
NDA 209905 · AZURITY
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213852 · RHODES PHARMS
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212186 · GLENMARK PHARMS LTD
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 214574 · SUN PHARM INDS INC
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213583 · SPECGX LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213720 · ALKEM LABS LTD
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213980 · EPIC PHARMA LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213763 · INGENUS PHARMS LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212901 · SENORES PHARMS
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 211861 · PRINSTON INC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212582 · SANALUZ
- 2019AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212919 · BIONPHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

